Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on HCP

Related HCP
Jim Cramer's Favorite REIT
Top 4 NYSE Stocks In The REIT-Healthcare Facilities Industry With The Highest EPS
Making Money With Charles Payne: 10/13/14 (Fox Business)

In a report published Friday, Jefferies & Company reiterated its Hold rating on HCP (NYSE: HCP), and slightly raised its price target from $45.00 to $46.00.

Jefferies noted, “We are updating our estimates for HCP and AMRE following announcements during the NAREIT conference in San Diego, CA. Our price target for HCP also increases to $46 from $45. See our accompanying note entitled ‘Tweets from NAREIT (November 2012 Edition)'.”

HCP closed on Thursday at $43.78.

Latest Ratings for HCP

Nov 2014Morgan StanleyUpgradesEqualweightOverweight
Oct 2014JefferiesDowngradesBuyHold
Oct 2014ISI GroupInitiates Coverage onNeutral

View More Analyst Ratings for HCP
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (HCP)

Around the Web, We're Loving...

Get Benzinga's Newsletters